RDIF, Hetero to produce over 100 million doses of Sputnik V vaccine in India, Top Health News | Latest Health & Healthcare Industry Information and Updates: ET HealthWorld : ETHealthworld.com

According to the second interim data analysis by Gamaleya Center and RDIF on November 24, the Sputnik V vaccine demonstrated a 91.4% efficacy rate in the evaluation carried out 28 days after administering the first dose., According to the second interim data analysis by Gamaleya Center and RDIF on November 24, the Sputnik V vaccine demonstrated a 91.4% efficacy rate in the evaluation carried out 28 days after administering the first dose., , Read More